FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lon Schneider

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Activities of Daily Living

Physiology

Cognition

Co-author Network

Publications

TOP 3
Lon S Schneider
Alzheimer disease pharmacologic treatment and treatment research.
Lon S Schneider
Quantifying an amyloid β model for Alzheimer's disease.
Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Lea T Drye; Constantine E Frangakis; Crystal Flynn Longmire; Constantine G Lyketsos; Barbara K Martin; Curtis L Meinert; Jacobo E Mintzer
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lon Schneider (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lon S Schneider
Alzheimer disease pharmacologic treatment and treatment research.
Continuum (Minneapolis, Minn.) 2013;19(2 Dementia):339-57.
2013: Lon S Schneider
Quantifying an amyloid β model for Alzheimer's disease.
Lancet neurology 2013;12(4):327-8.
2012: Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Lea T Drye; Constantine E Frangakis; Crystal Flynn Longmire; Constantine G Lyketsos; Barbara K Martin; Curtis L Meinert; Jacobo E Mintzer
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2012;20(12):1036-44.
2012: Richard E Kennedy; Lon S Schneider; Gary R Cutter
Biomarker positive and negative subjects in the ADNI cohort: clinical characterization.
Current Alzheimer research 2012;9(10):1135-41.
2012: Lon S Schneider
Ginkgo and AD: key negatives and lessons from GuidAge.
Lancet neurology 2012;11(10):836-7.
2012: Lon S Schneider
Recruitment methods for United States Alzheimer disease prevention trials.
The journal of nutrition, health & aging 2012;16(4):331-5.
2012: Edward Alan Miller; Robert A Rosenheck; Lon S Schneider
Caregiver burden, health utilities, and institutional service use in Alzheimer's disease.
International journal of geriatric psychiatry 2012;27(4):382-93.
2012: Lon S Schneider
Discontinuing donepezil or starting memantine for Alzheimer's disease.
The New England journal of medicine 2012;366(10):957-9.
2012: Paul S Aisen; Jeffrey Cummings; Lon S Schneider
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Cold Spring Harbor perspectives in medicine 2012;2(3):a006395.
2012: Lea T Drye; Constantine E Frangakis; Zahinoor Ismail; Constantine G Lyketsos; Christopher Mark Marano; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Gregory Pelton; Bruce G Pollock; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Jerome Yesavage; D P Devanand
Citalopram for agitation in Alzheimer's disease: design and methods.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2012;8(2):121-30.
2012: Somaia Mohamed; Robert Rosenheck; Richard Kaczynski; Constantine G Lyketsos; David L Sultzer; Lon S Schneider
Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.
The Journal of clinical psychiatry 2012;73(1):121-8.
2011: Matthew E Peters; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Vijay Vaidya; Daniel Weintraub; Dimitrios Avramopoulos; Avramopoulos Dimitri; Lea T Drye; Constantine E Frangakis; Constantine G Lyketsos; Barbara K Martin; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
Journal of geriatric psychiatry and neurology 2011;24(4):222-8.
2011: Alette M Wessels; Bruce G Pollock; Lon S Schneider; Scott Stroup; Robert R Bies; Kim C Coley; Margaret M Kirshner; Claire H Li; Jeffrey A Lieberman; Stephen R Marder
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.
Journal of clinical pharmacology 2011;51(11):1587-91.
2011: Liqin Zhao; Zisu Mao; Lon S Schneider; Roberta D Brinton
Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause.
Menopause (New York, N.Y.) 2011;18(10):1131-42.
2011: A S Fleisher; C R Jack; J B S Langbaum; J T Mai; Lon S Schneider; Pierre N. Tariot; R G Thomas; D Truran; M W Weiner; P S Aisen; J L Cummings
Chronic divalproex sodium use and brain atrophy in Alzheimer disease.
Neurology 2011;77(13):1263-71.
2011: Pierre N. Tariot; Leon J Thal; Ronald G Thomas; Michael W Weiner; Paul S Aisen; Barbara Bartocci; Jeffrey L Cummings; Adam Fleisher; M Saleem Ismail; Clifford R Jack; Laura J Jakimovich; Rebekah Loy; Anton Porsteinsson; Rema Raman; Lon S Schneider
Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
Archives of general psychiatry 2011;68(8):853-61.
2011: S Andrieu; J P Baeyens; J Beard; A Benetos; G Berrut; M Brainin; H B Cha; L K Chen; P Du; B Forette; F Forette; A Franco; L Fratiglioni; S Gillette-Guyonnet; G Gold; F Gomez; R Guimaraes; D Gustafson; A Khachaturian; Jose Luchsinger; F Mangialasche; H Mathiex-Fortunet; J P Michel; E Richard; Lon S Schneider; A Solomon; I Aboderin; Bruno Vellas
IAGG workshop: health promotion program on prevention of late onset dementia.
The journal of nutrition, health & aging 2011;15(7):562-75.
2011: Cheryl L P Vigen; Ling Zheng; Thomas Stroup; David L Sultzer; Pierre N. Tariot; Karen S Dagerman; John K Hsiao; Richard S E Keefe; Barry D Lebowitz; Constantine G Lyketsos; Wendy J Mack; Mary Sano; Lon S Schneider
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
The American journal of psychiatry 2011;168(8):831-9.
2011: Lon S Schneider; Karen S Dagerman; Julian P T Higgins; Rupert McShane
Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
Archives of neurology 2011;68(8):991-8.
2011: K Schafer; S De Santi; Lon S Schneider
Errors in ADAS-cog administration and scoring may undermine clinical trials results.
Current Alzheimer research 2011;8(4):373-6.
2011: Lea T Drye; Barbara K Martin; Constantine E Frangakis; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Constantine G Lyketsos
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
International journal of geriatric psychiatry 2011;26(6):573-83.
2011: Adam C Naj; Gyungah Jun; Gary Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew Huentelman; Amanda Myers; M. Michael Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Steven E Arnold; Robert C Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; dennis dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas Galasko; Mary Ganguli; Marla Gearing; Daniel Geschwind; Bernardino Ghetti; John Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C. Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret Pericak-Vance; Lindsay A Farrer; Peter St George-Hyslop; Gerard D Schellenberg
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nature genetics 2011;43(5):436-41.
2011: Mary Sano; Rema Raman; Jennifer Emond; Ronald G Thomas; Ronald C. Petersen; Lon S Schneider; Paul S Aisen
Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.
Alzheimer disease and associated disorders 2011;25(2):122-7.
2011: Helen C Kales; Kara Zivin; Hyungjin Myra Kim; Marcia Valenstein; Claire Chiang; Rosalinda V Ignacio; Dara Ganoczy; Francesca Cunningham; Lon S Schneider; Rosalinda V Ignacio; Frederic C Blow
Trends in antipsychotic use in dementia 1999-2007.
Archives of general psychiatry 2011;68(2):190-7.
2011: Ralf Ihl; Lutz Frölich; Bengt Winblad; Lon S Schneider; Alistair Burns; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(1):2-32.
2011: Edward Alan Miller; Lon S Schneider; Robert A Rosenheck
Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
International psychogeriatrics / IPA 2011;23(1):44-53.
2011: todd golde; Lon S Schneider; Edward H Koo
Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.
Neuron 2011;69(2):203-13.
2011: P S Aisen; S Andrieu; Cristina Sampaio; M Carrillo; ZAVEN KHACHATURIAN; B Dubois; H H Feldman; Ronald C. Petersen; E Siemers; Rachelle S Doody; S B Hendrix; M Grundman; Lon S Schneider; R J Schindler; E Salmon; W Z Potter; R G Thomas; D Salmon; M Donohue; M M Bednar; J Touchon; Bruno Vellas
Report of the task force on designing clinical trials in early (predementia) AD.
Neurology 2011;76(3):280-6.
2011: Lon S Schneider; Philip S Insel; Michael Weiner
Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative.
Archives of neurology 2011;68(1):58-66.
2010: Alette M Wessels; Bruce G Pollock; Norbert G Anyama; Lon S Schneider; Jeffrey A Lieberman; Stephen R Marder; Robert R Bies
Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial.
Journal of clinical psychopharmacology 2010;30(6):683-7.
2010: Lon S Schneider
Fixing Alzheimer disease trials by improving process and methods.
Current Alzheimer research 2010;7(7):564-5.
2010: Lon S Schneider
Organising the language of Alzheimer's disease in light of biomarkers.
Lancet neurology 2010;9(11):1044-5.
2010: Somaia Mohamed; Robert Rosenheck; Constantine G Lyketsos; Lon S Schneider
Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(10):917-27.
2010: Lon S Schneider; Richard E Kennedy; Gary R Cutter
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(5):367-77.
2010: Edward Alan Miller; R A Rosenheck; Lon S Schneider
Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study.
Current Alzheimer research 2010;7(4):348-57.
2010: Lon S Schneider
The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.
The journal of nutrition, health & aging 2010;14(4):295-8.
2010: Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine E Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(4):332-40.
2010: ZAVEN KHACHATURIAN; Deborah Barnes; Richard Einstein; Sterling Johnson; Virginia M-Y Lee; Allen D Roses; Mark A Sager; William R Shankle; Peter J Snyder; Ronald C. Petersen; Gerard D Schellenberg; John Q Trojanowski; Paul Aisen; Marilyn S Albert; John C S Breitner; Neil Buckholtz; Maria Carrillo; Steven Ferris; Barry D Greenberg; Michael Grundman; Ara S Khachaturian; Lewis H Kuller; Oscar L Lopez; Paul Maruff; Richard C Mohs; Marcelle Morrison-Bogorad; Creighton Phelps; Eric Reiman; Marwan Sabbagh; Mary Sano; Lon S Schneider; Eric Siemers; Pierre Tariot; Jacques Touchon; Bruno Vellas; Lisa J Bain
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(2):89-97.
2010: Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine E Frangakis; Jacobo E Mintzer; Daniel Weintraub; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Sertraline for the treatment of depression in Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(2):136-45.
2010: Lon S Schneider
Care plans for people with Alzheimer's disease.
BMJ (Clinical research ed.) 2010;340():c2626.
2010: Yuyan Jin; Bruce G Pollock; Kim C Coley; Del Miller; Stephen R Marder; Jeff Florian; Lon S Schneider; Jeffrey Lieberman; Margaret A Kirshner; Robert R Bies
Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking.
Journal of clinical pharmacology 2010;50(1):73-80.
2009: Robert C Green; Lon S Schneider; David A Amato; Andrew P Beelen; Gordon K Wilcock; Edward A Swabb; Kenton H Zavitz
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2009;302(23):2557-64.
2009: Lon S Schneider; Mary Sano
Current Alzheimer's disease clinical trials: methods and placebo outcomes.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(5):388-97.
2009: Lon S Schneider; Rema Raman; Frederick A Schmitt; Rachelle S Doody; Philip Insel; Christopher M Clark; John C Morris; Barry Reisberg; Ronald C. Petersen; Steven H Ferris
Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials.
Alzheimer disease and associated disorders 2009;23(3):260-7.
2009: Ling Zheng; Wendy Mack; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Thomas Stroup; David L Sultzer; Pierre N. Tariot; Cheryl Vigen; Lon S Schneider
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.
The American journal of psychiatry 2009;166(5):583-90.
2009: J Craig Nelson; Kevin Delucchi; Lon S Schneider
Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
International journal of geriatric psychiatry 2009;24(5):539-44.
2009: Lon S Schneider
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(2):172-9.
2009: ZAVEN KHACHATURIAN; Peter J Snyder; Rachelle S Doody; Paul S Aisen; Meryl Comer; John Dwyer; Richard A Frank; Andrew Holzapfel; Ara Khachaturian; Amos D Korczyn; Allen D Roses; James W Simpkins; Lon S Schneider; Marilyn S Albert; Robert Egge; Aaron Deves; Steven Ferris; Barry D Greenberg; Carl Johnson; Walter A Kukull; Judes Poirier; Dale Schenk; William Thies; S Gauthier; Sid Gilman; Charles Bernick; Jeffrey L Cummings; Howard Fillit; Michael Grundman; Jeffrey A Kaye; Lennart Mucke; Barry Reisberg; Mary Sano; Oxana Pickeral; Ronald C. Petersen; Richard C Mohs; Maria Carrillo; Jody Corey-Bloom; Norman L Foster; Steve Jacobsen; Virginia M-Y Lee; William Z Potter; Marwan Sabbagh; David P Salmon; John Q Trojanowski; Nancy Wexler; Lisa J Bain
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(2):85-92.
2009: Lon S Schneider; Debomoy K Lahiri
The perils of Alzheimer's drug development.
Current Alzheimer research 2009;6(1):77-8.
2009: Edward Alan Miller; Lon S Schneider; Robert A Rosenheck
Assessing the relationship between health utilities, quality of life, and health services use in Alzheimer's disease.
International journal of geriatric psychiatry 2009;24(1):96-105.
2008: Edward Alan Miller; Lon S Schneider; Arthur Zbrozek; Robert A Rosenheck
Sociodemographic and clinical correlates of utility scores in Alzheimer's disease.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(7):1120-30.
2008: Lon S Schneider
Ginkgo biloba extract and preventing Alzheimer disease.
JAMA : the journal of the American Medical Association 2008;300(19):2306-8.
2008: Yan Feng; Bruce G Pollock; Kim Coley; Stephen Marder; Del Miller; Margaret Kirshner; Manickam Aravagiri; Lon S Schneider; Robert R Bies
Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.
British journal of clinical pharmacology 2008;66(5):629-39.
2008: James P O'Halloran; Aaron S Kemp; Kirstan N Gooch; Philip D Harvey; Barton W Palmer; Christopher Reist; Lon S Schneider
Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia.
Schizophrenia research 2008;106(1):33-41.
2008: Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald Thomas; Leon J Thal
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;300(15):1774-83.
2008: J Craig Nelson; Kevin Delucchi; Lon S Schneider
Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(7):558-67.
2008: David L Sultzer; Sonia M Davis; Pierre N. Tariot; Karen S Dagerman; Barry D Lebowitz; Constantine G Lyketsos; Robert A Rosenheck; John K Hsiao; Jeffrey A Lieberman; Lon S Schneider
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
The American journal of psychiatry 2008;165(7):844-54.
2008: Edmond Teng; John M Ringman; Leslie K Ross; Ruth A Mulnard; Malcolm B Dick; George Bartzokis; Helen D Davies; Douglas Galasko; Linda Hewett; Dan Mungas; Bruce R Reed; Lon S Schneider; Freddi Segal-Gidan; Kristine Yaffe; Jeffrey L Cummings
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(6):469-77.
2008: ZAVEN KHACHATURIAN; Ronald C. Petersen; S Gauthier; Neil Buckholtz; Jody Corey-Bloom; Bill Evans; Howard Fillit; Norman Foster; Barry Greenberg; Michael Grundman; Mary Sano; James Simpkins; Lon S Schneider; Michael Weiner; Douglas Galasko; Bradley T Hyman; Lew Kuller; Dale Schenk; Stephen Snyder; Ronald Thomas; Mark H Tuszynski; Bruno Vellas; Richard J Wurtman; Peter J Snyder; Richard A Frank; Marilyn S Albert; Rachelle S Doody; Steven H Ferris; Jeffrey A Kaye; Edward H Koo; Marcelle Morrison-Bogorad; Barry Reisberg; David P Salmon; Sid Gilman; Richard C Mohs; Paul S Aisen; John C S Breitner; Jeffrey L Cummings; Claudia Kawas; Creighton Phelps; Judes Poirier; Marwan Sabbagh; Jacques Touchon; Ara Khachaturian; Lisa J Bain
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(3):156-63.
2008: Lon S Schneider
Does donepezil improve executive function in patients with CADASIL?
Lancet neurology 2008;7(4):287-9.
2008: Dilip V Jeste; Dan Blazer; Daniel E Casey; Thomas Meeks; Carl Salzman; Lon S Schneider; Pierre N. Tariot; Kristine Yaffe
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(5):957-70.
2008: Kristin L Bigos; Bruce G Pollock; Kim C Coley; Del D Miller; Stephen R Marder; Manickam Aravagiri; Margaret A Kirshner; Lon S Schneider; Robert R Bies
Sex, race, and smoking impact olanzapine exposure.
Journal of clinical pharmacology 2008;48(2):157-65.
2008: Lon S Schneider
Prevention therapeutics of dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(1 Suppl 1):S122-30.
2007: Peter V Rabins; Deborah Blacker; Barry W Rovner; Teresa Rummans; Lon S Schneider; Pierre N. Tariot; David M Blass; John S McIntyre; Sara C Charles; Daniel J Anzia; Ian A Cook; Molly T Finnerty; Bradley R Johnson; James E Nininger; Barbara Schneidman; Paul Summergrad; Sherwyn M Woods; Joseph Berger; C Deborah Cross; Harry A Brandt; Philip M Margolis; John P D Shemo; Barton J Blinder; David L Duncan; Mary Ann Barnovitz; Anthony J Carino; Zachary Z Freyberg; Sheila Hafter Gray; Tina Tonnu; Robert Kunkle; Amy B Albert; Thomas J Craig; Darrel A Regier; Laura J Fochtmann
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition.
The American journal of psychiatry 2007;164(12 Suppl):5-56.
2007: Robert A Rosenheck; Douglas L Leslie; Jody L Sindelar; Edward A Miller; Pierre N. Tariot; Karen S Dagerman; Sonia M Davis; Barry D Lebowitz; Peter V Rabins; John K Hsiao; Jeffery A Lieberman; Lon S Schneider
Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.
Archives of general psychiatry 2007;64(11):1259-68.
2007: Harish Kavirajan; Lon S Schneider
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Lancet neurology 2007;6(9):782-92.
2007: M Saleem Ismail; Karen S Dagerman; Pierre N. Tariot; Shana Abbott; Sarah Kavanagh; Lon S Schneider
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics.
Current Alzheimer research 2007;4(3):325-35.
2007: Carolee J Winstein; Kirk R Bentzen; Lara Boyd; Lon S Schneider
Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease?
Current Alzheimer research 2007;4(3):273-6.
2007: J Craig Nelson; Kevin Delucchi; Lon S Schneider
Suicidal thinking and behavior during treatment with sertraline in late-life depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2007;15(7):573-80.
2007: Steven H Ferris; Lon S Schneider; Mildred Farmer; Gary Kay; Thomas Crook
A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).
International journal of geriatric psychiatry 2007;22(5):448-55.
2007: Lon S Schneider
Commentary on "Meta-analysis of six-month memantine trials in Alzheimer's disease." Wuthering forest plots: distinguishing the forest from the plots.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2007;3(1):18-20.
2006: Barbara K Martin; Constantine E Frangakis; Paul B Rosenberg; Jacobo E Mintzer; Ira R Katz; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; George Niederehe; Constantine G Lyketsos
Design of Depression in Alzheimer's Disease Study-2.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(11):920-30.
2006: Lon S Schneider; Pierre N. Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; Thomas Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
The New England journal of medicine 2006;355(15):1525-38.
2006: Lon S Schneider; Christopher M Clark; Rachelle S Doody; Steven H Ferris; John C Morris; Rema Raman; Barry Reisberg; Frederick A Schmitt
ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S124-38.
2006: Steven H Ferris; Paul S Aisen; Jeffrey L Cummings; Douglas Galasko; David P Salmon; Lon S Schneider; Mary Sano; Peter J Whitehouse; Steven D Edland; Leon J Thal
ADCS Prevention Instrument Project: overview and initial results.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S109-23.
2006: Pierre N. Tariot; Lon S Schneider; Ira R Katz; Jacobo E Mintzer; Jamie Street; Margaret Copenhaver; Celeste Williams-Hughes
Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(9):767-76.
2006: Lon S Schneider
Open-label extension studies and misinformation.
Archives of neurology 2006;63(7):1036; author reply 1036-7.
2006: Jacobo E Mintzer; Andrew Greenspan; Ivo Caers; Ilse Van Hove; Stuart Kushner; Myron Weiner; Georges Gharabawi; Lon S Schneider
Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(3):280-91.
2006: Lon S Schneider; Karen S Dagerman; Philip S Insel
Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(3):191-210.
2006: JM López-Arrieta; Lon S Schneider
Metrifonate for Alzheimer's disease.
Cochrane database of systematic reviews (Online) 2006;(2):CD003155.
2006: C Loy; Lon S Schneider
Galantamine for Alzheimer's disease and mild cognitive impairment.
Cochrane database of systematic reviews (Online) 2006;(1):CD001747.
2006: Lon S Schneider
The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
International journal of geriatric psychiatry 2006;21(1):9-13.
2005: Lon S Schneider; Steven T DeKosky; Martin R Farlow; Pierre N. Tariot; Robert Hoerr; Meinhard Kieser
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
Current Alzheimer research 2005;2(5):541-51.
2005: Pierre N. Tariot; Rema Raman; Laura Jakimovich; Lon S Schneider; Anton P Porsteinsson; Ronald Thomas; Jacobo E Mintzer; Ronald Brenner; Kimberly Schafer; Leon J Thal
Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(11):942-9.
2005: Lon S Schneider; Karen S Dagerman; Philip Insel
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
JAMA : the journal of the American Medical Association 2005;294(15):1934-43.
2005: Lon S Schneider
Drug development, clinical trials, cultural heterogeneity in Alzheimer disease: the need for pro-active recruitment.
Alzheimer disease and associated disorders 2005;19(4):279-83.
2005: Lon S Schneider
Mild cognitive impairment.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(8):629-32.
2005: Rupert McShane; Lon S Schneider
Meta-analysis of memantine: summary and commentary on the Cochrane Collaboration's systematic review.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2005;1(1):67-71.
2005: J Craig Nelson; Cathryn M Clary; Andrew C Leon; Lon S Schneider
Symptoms of late-life depression: frequency and change during treatment.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(6):520-6.
2005: Paul B Rosenberg; CHIADIKAOBI ONYIKE; Ira R Katz; Anton P Porsteinsson; Jacobo E Mintzer; Lon S Schneider; Peter V Rabins; Curtis L Meinert; Barbara K Martin; Constantine G Lyketsos
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.
International journal of geriatric psychiatry 2005;20(2):119-27.
2004: Ira R Katz; Marcia F T Rupnow; Chris Kozma; Lon S Schneider
Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(5):499-508.
2004: Jeanne M Jackson-Siegal; Lon S Schneider; Andrius Baskys; Daniel W Haupt
Recognizing and responding to atypical antipsychotic side effects.
Journal of the American Medical Directors Association 2004;5(4 Suppl):H7-10.
2004: Douglas Galasko; Paul Kershaw; Lon S Schneider; Young Zhu; Pierre N. Tariot
Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease.
Journal of the American Geriatrics Society 2004;52(7):1070-6.
2004: Lon S Schneider
AD2000: donepezil in Alzheimer's disease.
Lancet 2004;363(9427):2100-1.
2004: Lon S Schneider
Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
JAMA : the journal of the American Medical Association 2004;291(24):3005-7.
2004: Lon S Schneider; Nawab Qizilbash
Delay in nursing home placement with donepezil.
Journal of the American Geriatrics Society 2004;52(6):1024-6; author reply 1026-7.
2004: Lon S Schneider
Venlafaxine offers no benefit over sertraline and is less well tolerated in depressed nursing home residents.
Evidence-based mental health 2004;7(2):47.
2004: Jeffrey L Cummings; Lon S Schneider; Pierre N. Tariot; Paul Kershaw; Weiying Yuan
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.
The American journal of psychiatry 2004;161(3):532-8.
2004: Clement T Loy; Lon S Schneider
Galantamine for Alzheimer's disease.
Cochrane database of systematic reviews (Online) 2004;(4):CD001747.
2004: Lon S Schneider; Karen S Dagerman
Psychosis of Alzheimer's disease: clinical characteristics and history.
Journal of psychiatric research 2004;38(1):105-11.
2003: Stephen J Bartels; Aricca R Dums; Thomas E Oxman; Lon S Schneider; Patricia A Areán; George S Alexopoulos; Dilip V Jeste
Evidence-based practices in geriatric mental health care: an overview of systematic reviews and meta-analyses.
The Psychiatric clinics of North America 2003;26(4):971-90, x-xi.
2003: Lon S Schneider
Cholinesterase inhibitors for vascular dementia?
Lancet neurology 2003;2(11):658-9.
2003: Mark Hyman Rapaport; Lon S Schneider; David L Dunner; John T Davies; Cornelius D Pitts
Efficacy of controlled-release paroxetine in the treatment of late-life depression.
The Journal of clinical psychiatry 2003;64(9):1065-74.
2003: Lon S Schneider; Anton P Porsteinsson; Elaine R Peskin; Eric A Pfeiffer
Choosing treatment for Alzheimer's patients and their caregivers.
Geriatrics 2003;58 Suppl 1():3-18, 23; quiz 19-22.
2003: Lon S Schneider; Ira R Katz; Sohee Park; Judy Napolitano; Rick A Martinez; Stanley P Azen
Psychosis of Alzheimer disease: validity of the construct and response to risperidone.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(4):414-25.
2003: Lon S Schneider; J Craig Nelson; Cathryn M Clary; Paul Newhouse; K Ranga Rama Krishnan; Thomas Shiovitz; Karen L Weihs
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
The American journal of psychiatry 2003;160(7):1277-85.
2003: Lon S Schneider
Cholinesterase inhibitors for Alzheimer disease.
JAMA : the journal of the American Medical Association 2003;289(18):2359-60; author reply 2360-1.
2003: Leon J Thal; Ronald Thomas; Ruth Mulnard; Mary Sano; Michael Grundman; Lon S Schneider
Estrogen levels do not correlate with improvement in cognition.
Archives of neurology 2003;60(2):209-12.
2003: Debomoy K Lahiri; Martin R Farlow; Kumar Sambamurti; Nigel H Greig; Ezio Giacobini; Lon S Schneider
A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.
Current drug targets 2003;4(2):97-112.
2003: Jason T Olin; Lon S Schneider; Ira R Katz; Barnett S Meyers; George S Alexopoulos; John C S Breitner; Martha L Bruce; Eric D Caine; Jeffrey L Cummings; Davangere P Devanand; Dilip V Jeste; K Ranga Rama Krishnan; Constantine G Lyketsos; Jeffrey M Lyness; Peter V Rabins; Charles F Reynolds Iii; Barry W Rovner; David C Steffens; Jürgen Unützer; Barry D Lebowitz
Provisional diagnostic criteria for depression of Alzheimer's disease: description and review.
Expert review of neurotherapeutics 2003;3(1):99-106.
2003: Lon S Schneider; M Saleem Ismail; Karen S Dagerman; Sonia M Davis; Jason Olin; Dennis McManus; Eric Pfeiffer; J Michael Ryan; David L Sultzer; Pierre N. Tariot
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
Schizophrenia bulletin 2003;29(1):57-72.
2002: Stephen Salloway; Stephen Correia; Patricia A Boyle; Paul F Malloy; Lon S Schneider; Helen Lavretsky; Harold Sackheim; Steven Roose; K Ranga Rama Krishnan
MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
Journal of the neurological sciences 2002;203-204():227-33.
2002: Stephen J Bartels; Aricca R Dums; Thomas E Oxman; Lon S Schneider; Patricia A Areán; George S Alexopoulos; Dilip V Jeste
Evidence-based practices in geriatric mental health care.
Psychiatric services (Washington, D.C.) 2002;53(11):1419-31.
2002: Lon S Schneider; Gary W Small
The increasing power of placebos in trials of antidepressants.
JAMA : the journal of the American Medical Association 2002;288(4):450.
2002: Jeffrey Lieberman; Scott Stroup; Lon S Schneider
Prevention of relapse in schizophrenia.
The New England journal of medicine 2002;346(18):1412-3; author reply 1412-3.
2002: Lon S Schneider
Galantamine for vascular dementia: some answers, some questions.
Lancet 2002;359(9314):1265-6.
2002: Jason T Olin; Ira R Katz; Barnett S Meyers; Lon S Schneider; Barry D Lebowitz
Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(2):129-41.
2002: Jason T Olin; Lon S Schneider; Ira R Katz; Barnett S Meyers; George S Alexopoulos; John C S Breitner; Martha L Bruce; Eric D Caine; Jeffrey L Cummings; Davangere P Devanand; K Ranga Rama Krishnan; Constantine G Lyketsos; Jeffrey M Lyness; Peter V Rabins; Charles F Reynolds; Barry W Rovner; David C Steffens; Pierre N. Tariot; Barry D Lebowitz
Provisional diagnostic criteria for depression of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(2):125-8.
2002: Jason T Olin; Karen S Dagerman; Lauren S Fox; Beth Bowers; Lon S Schneider
Increasing ethnic minority participation in Alzheimer disease research.
Alzheimer disease and associated disorders 2002;16 Suppl 2():S82-5.
2002: Rochelle E Tractenberg; Anthony Gamst; Ronald Thomas; Marian Patterson; Lon S Schneider; Leon J Thal
Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease.
The Journal of neuropsychiatry and clinical neurosciences 2002;14(3):303-10.
2002: Jason Olin; Lon S Schneider
Galantamine for Alzheimer's disease.
Cochrane database of systematic reviews (Online) 2002;(3):CD001747.
2002: Stephen Salloway; Patricia A Boyle; Stephen Correia; Paul F Malloy; Deborah A Cahn-Weiner; Lon S Schneider; K Ranga Rama Krishnan; Raj Nakra
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(1):107-11.
2001: Lon S Schneider
Assessing outcomes in Alzheimer disease.
Alzheimer disease and associated disorders 2001;15 Suppl 1():S8-18.
2001: Bengt Winblad; H Brodaty; S Gauthier; John C Morris; J M Orgogozo; kenneth rockwood; Lon S Schneider; Masatoshi Takeda; Pierre N. Tariot; D Wilkinson
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
International journal of geriatric psychiatry 2001;16(7):653-66.
2001: Pierre N. Tariot; J Michael Ryan; Anton P Porsteinsson; Rebekah Loy; Lon S Schneider
Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.
Clinics in geriatric medicine 2001;17(2):359-76.
2001: Lon S Schneider
Treatment of Alzheimer's disease with cholinesterase inhibitors.
Clinics in geriatric medicine 2001;17(2):337-58.
2001: Jason T Olin; Lauren S Fox; S Pawluczyk; N A Taggart; Lon S Schneider
A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2001;9(4):400-5.
2001: Lon S Schneider; Gary W Small; Cathryn M Clary
Estrogen replacement therapy and antidepressant response to sertraline in older depressed women.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2001;9(4):393-9.
2001: Lon S Schneider; Pierre N. Tariot; Constantine G Lyketsos; Karen S Dagerman; Kenneth L Davis; Sonia M Davis; John K Hsiao; D V Jeste; Ira R Katz; Jason T Olin; B G Pollock; Peter V Rabins; Robert A Rosenheck; Gary W Small; Barry D Lebowitz; Jeffrey A Lieberman
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2001;9(4):346-60.
2001: Jason Olin; Lon S Schneider
Galantamine for Alzheimer's disease.
Cochrane database of systematic reviews (Online) 2001;(4):CD001747.
2001: Jason Olin; Lon S Schneider; Adrian D Novit; S Luczak
Hydergine for dementia.
Cochrane database of systematic reviews (Online) 2001;(2):CD000359.
2001: Jason Olin; Lon S Schneider
Galantamine for Alzheimer's disease.
Cochrane database of systematic reviews (Online) 2001;(1):CD001747.
2000: Linda Teri; Rebecca G Logsdon; Elaine Peskind; Murray A Raskind; Myron Weiner; Rochelle E Tractenberg; Norman L Foster; Lon S Schneider; Mary Sano; Peter J Whitehouse; Pierre N. Tariot; Alan M Mellow; A P Auchus; Michael Grundman; Ronald Thomas; Kimberly Schafer; Leon J Thal
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Neurology 2000;55(9):1271-8.
2000: Rochelle E Tractenberg; S Jin; M Patterson; Lon S Schneider; Anthony Gamst; Ronald Thomas; Leon J Thal
Qualifying change: a method for defining clinically meaningful outcomes of change score computation.
Journal of the American Geriatrics Society 2000;48(11):1478-82.
2000: Rachelle S Doody; Shaheda N Azher; Hani Haykal; J Kay Dunn; T Liao; Lon S Schneider
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?
Journal of neurology, neurosurgery, and psychiatry 2000;69(5):668-71.
2000: Lon S Schneider
Metrifonate for Alzheimer's disease patients.
The Journal of clinical psychiatry 2000;61(3):218-9.
2000: Jason Olin; Lon S Schneider; Adrian D Novit; S Luczak
Hydergine for dementia.
Cochrane database of systematic reviews (Online) 2000;(2):CD000359.
1999: C G Ippen; Jason T Olin; Lon S Schneider
Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1999;7(4):321-30.
1999: Lon S Schneider
Pharmacologic management of psychosis in dementia.
The Journal of clinical psychiatry 1999;60 Suppl 8():54-60.
1999: Laura P Sands; I Katz; Lon S Schneider
Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors.
Alzheimer disease and associated disorders 1999;13(1):26-33.
1998: Nawab Qizilbash; A Whitehead; J Higgins; Gordon K Wilcock; Lon S Schneider; Martin R Farlow
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
JAMA : the journal of the American Medical Association 1998;280(20):1777-82.
1998: Lauren S Fox; Jason T Olin; Joel Erblich; C G Ippen; Lon S Schneider
Severity of cognitive impairment in Alzheimer's disease affects list learning using the California Verbal Learning Test (CVLT).
International journal of geriatric psychiatry 1998;13(8):544-9.
1998: Lon S Schneider
Advances in the treatment of Alzheimer's disease.
Aging (Milan, Italy) 1998;10(2):156-7.
1998: Martin R Farlow; Debomoy K Lahiri; J Poirier; J Davignon; Lon S Schneider; Siu L Hui
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.
Neurology 1998;50(3):669-77.
1998: David S. Knopman; Lon S Schneider; Kenneth L Davis; S Gracon; F Smith
Long-term tacrine treatment effects.
Neurology 1998;50(2):567-8.
1998: Lon S Schneider
New therapeutic approaches to cognitive impairment.
The Journal of clinical psychiatry 1998;59 Suppl 11():8-13.
1998: Lon S Schneider
Introduction. Alzheimer's disease: from research to practice.
The Journal of clinical psychiatry 1998;59 Suppl 11():3.
1998: Lon S Schneider
Cholinergic deficiency in Alzheimer's disease. Pathogenic model.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1998;6(2 Suppl 1):S49-55.
1998: Peter N R Heseltine; Karl Goodkin; J Hampton Atkinson; Benedetto Vitiello; J Rochon; R K Heaton; E M Eaton; Frances L Wilkie; E Sobel; S J Brown; Daniel J Feaster; Lon S Schneider; W L Goldschmidts; E S Stover
Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
Archives of neurology 1998;55(1):41-51.
1997: Gary W Small; Peter V Rabins; P P Barry; N S Buckholtz; Steven T DeKosky; Steven H Ferris; S I Finkel; L P Gwyther; ZAVEN KHACHATURIAN; B D Lebowitz; Thomas McRae; John C Morris; F Oakley; Lon S Schneider; J E Streim; Trey Sunderland; Linda Teri; Larry E Tune
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
JAMA : the journal of the American Medical Association 1997;278(16):1363-71.
1997: Barry D Lebowitz; Jane L Pearson; Lon S Schneider; Charles F Reynolds; George S Alexopoulos; M L Bruce; Y Conwell; Ira R Katz; Barnett S Meyers; Mary F Morrison; J Mossey; George Niederehe; Patricia Parmelee
Diagnosis and treatment of depression in late life. Consensus statement update.
JAMA : the journal of the American Medical Association 1997;278(14):1186-90.
1997: Lon S Schneider; Martin R Farlow
Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.
Annals of the New York Academy of Sciences 1997;826():317-22.
1997: Lon S Schneider; Martin R Farlow; Janice M Pogoda
Potential role for estrogen replacement in the treatment of Alzheimer's dementia.
The American journal of medicine 1997;103(3A):46S-50S.
1997: Lon S Schneider; Caleb E Finch
Can estrogens prevent neurodegeneration?
Drugs & aging 1997;11(2):87-95.
1997: Lon S Schneider; Jason T Olin; Scott A Lyness; Helena C Chui
Eligibility of Alzheimer's disease clinic patients for clinical trials.
Journal of the American Geriatrics Society 1997;45(8):923-8.
1997: Pierre N. Tariot; Lon S Schneider; Anton P Porsteinsson
Treating Alzheimer's disease. Pharmacologic options now and in the near future.
Postgraduate medicine 1997;101(6):73-6, 81, 84 passim.
1997: J Galen Buckwalter; Lon S Schneider; T W Wilshire; M E Dunn; Victor W. Henderson
Body weight, estrogen and cognitive functioning in Alzheimer's disease: an analysis of the Tacrine Study Group data.
Archives of gerontology and geriatrics 1997;24(3):261-7.
1997: Mary Sano; C Ernesto; Ronald Thomas; M R Klauber; Kimberly Schafer; Michael Grundman; P Woodbury; John H Growdon; Carl W Cotman; Eric Pfeiffer; Lon S Schneider; Leon J Thal
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
The New England journal of medicine 1997;336(17):1216-22.
1997: C A Class; Lon S Schneider; Martin R Farlow
Optimal management of behavioural disorders associated with dementia.
Drugs & aging 1997;10(2):95-106.
1997: Leon J Thal; A Carta; Rachelle S Doody; P Leber; Richard C Mohs; Lon S Schneider; S Shimohama; C Silber
Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():46-9.
1997: Barry Reisberg; Lon S Schneider; Rachelle S Doody; R Anand; H Feldman; H Haraguchi; R Kumar; U Lucca; C A Mangone; E Mohr; John C Morris; S Rogers; T Sawada
Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():8-18.
1997: Joan A Mackell; Steven H Ferris; Richard C Mohs; Lon S Schneider; Douglas Galasko; Peter J Whitehouse; F Schmitt; Mary Sano; Leon J Thal
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S65-9.
1997: Frederick A Schmitt; W Ashford; C Ernesto; J Saxton; Lon S Schneider; C M Clark; Steven H Ferris; Joan A Mackell; Kimberly Schafer; Leon J Thal
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S51-6.
1997: Lon S Schneider; Jason T Olin; Rachelle S Doody; C M Clark; John C Morris; Barry Reisberg; Frederick A Schmitt; Michael Grundman; Ronald Thomas; Steven H Ferris
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S22-32.
1997: Steven H Ferris; Joan A Mackell; Richard C Mohs; Lon S Schneider; Douglas Galasko; Peter J Whitehouse; Frederick A Schmitt; Mary Sano; Ronald Thomas; C Ernesto; Michael Grundman; Kimberly Schafer; Leon J Thal
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S1-12.
1997: B D Lebowitz; Bruce G Pollock; Lon S Schneider
Estrogen in geriatric psychopharmacology.
Psychopharmacology bulletin 1997;33(2):287-8.
1997: Lon S Schneider; Gary W Small; S H Hamilton; Alexander Bystritsky; Charles Nemeroff; Barnett S Meyers
Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1997;5(2):97-106.
1996: J T Olin; Lon S Schneider; Rachelle S Doody; C M Clark; Steven H Ferris; John C Morris; Barry Reisberg; Frederick A Schmitt
Clinical evaluation of global change in Alzheimer's disease: identifying consensus.
Journal of geriatric psychiatry and neurology 1996;9(4):176-80.
1996: David S. Knopman; Lon S Schneider; Kenneth L Davis; S Talwalker; F Smith; T Hoover; S Gracon
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.
Neurology 1996;47(1):166-77.
1996: Lon S Schneider; Martin R Farlow; Victor W. Henderson; Janice M Pogoda
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.
Neurology 1996;46(6):1580-4.
1996: Lon S Schneider
Meta-analysis of controlled pharmacologic trials.
International psychogeriatrics / IPA 1996;8 Suppl 3():375-9; discussion 381-2.
1996: Lon S Schneider
New therapeutic approaches to Alzheimer's disease.
The Journal of clinical psychiatry 1996;57 Suppl 14():30-6.
1996: Lon S Schneider; J T Olin
Clinical global impressions in Alzheimer's clinical trials.
International psychogeriatrics / IPA 1996;8(2):277-88; discussion 288-90.
1996: Lon S Schneider
Overview of generalized anxiety disorder in the elderly.
The Journal of clinical psychiatry 1996;57 Suppl 7():34-45; discussion 52-4.
1995: Lon S Schneider; Scott A Lyness
Is platelet imipramine binding reduced in depression? A meta-analysis by Ellis and Salmond.
Biological psychiatry 1995;38(11):775-6.
1995: Pierre N. Tariot; Lon S Schneider; I R Katz
Anticonvulsant and other non-neuroleptic treatment of agitation in dementia.
Journal of geriatric psychiatry and neurology 1995;8 Suppl 1():S28-39.
1995: L E Holt; Adrian Raine; G Pa; Lon S Schneider; Victor W. Henderson; V E Pollock
P300 topography in Alzheimer's disease.
Psychophysiology 1995;32(3):257-65.
1995: Lon S Schneider; J T Olin
Efficacy of acute treatment for geriatric depression.
International psychogeriatrics / IPA 1995;7 Suppl():7-25.
1995: Barry D Lebowitz; R A Martinez; G Niederehe; J L Pearson; C F Reynolds; M V Rudorfer; Lon S Schneider; D J Kupfer
NIMH/MacArthur Foundation workshop report. Treatment of depression in late life.
Psychopharmacology bulletin 1995;31(1):185-202.
1994: Lon S Schneider; Pierre N. Tariot; B Goldstein
Therapy with l-deprenyl (selegiline) and relation to abuse liability.
Clinical pharmacology and therapeutics 1994;56(6 Pt 2):750-6.
1994: Lon S Schneider; J T Olin
Overview of clinical trials of hydergine in dementia.
Archives of neurology 1994;51(8):787-98.
1994: Lon S Schneider; Pierre N. Tariot
Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications.
The Medical clinics of North America 1994;78(4):911-34.
1994: Helena C Chui; Scott A Lyness; E Sobel; Lon S Schneider
Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.
Archives of neurology 1994;51(7):676-81.
1994: Scott A Lyness; E M Eaton; Lon S Schneider
Cognitive performance in older and middle-aged depressed outpatients and controls.
Journal of gerontology 1994;49(3):P129-36.
1993: Lon S Schneider; J T Olin; S Pawluczyk
A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease.
The American journal of psychiatry 1993;150(2):321-3.
1993: Charles F Reynolds; B D Lebowitz; Lon S Schneider
The NIH Consensus Development Conference on the Diagnosis and Treatment of Depression in Late Life: an overview.
Psychopharmacology bulletin 1993;29(1):83-5.
1993: Lon S Schneider
Efficacy of treatment for geropsychiatric patients with severe mental illness.
Psychopharmacology bulletin 1993;29(4):501-24.
1992: Kenneth L Davis; Leon J Thal; E R Gamzu; C S Davis; Robert F Woolson; S I Gracon; David Drachman; Lon S Schneider; Peter J Whitehouse; T M Hoover
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
The New England journal of medicine 1992;327(18):1253-9.
1992: V E Pollock; Lon S Schneider
P3 from auditory stimuli in healthy elderly subjects: hearing threshold and tone stimulus frequency.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 1992;12(3):237-41.
1992: Lon S Schneider
Tracking dementia by the IMC and the MMSE.
Journal of the American Geriatrics Society 1992;40(5):537-8.
1992: Lon S Schneider
Psychobiologic features of geriatric affective disorder.
Clinics in geriatric medicine 1992;8(2):253-65.
1992: V E Pollock; Lon S Schneider
Reliability of late positive component activity (P3) in healthy elderly adults.
Journal of gerontology 1992;47(3):M88-92.
1992: V E Pollock; Lon S Schneider; M F Zemansky; R P Gleason; S Pawluczyk
Topographic quantitative EEG amplitude in recovered alcoholics.
Psychiatry research 1992;45(1):25-32.
1992: S Caldecott-Hazard; Lon S Schneider
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.
Synapse (New York, N.Y.) 1992;10(2):141-68.
1992: Lon S Schneider; M Hinsey; Scott A Lyness
Plasma dehydroepiandrosterone sulfate in Alzheimer's disease.
Biological psychiatry 1992;31(2):205-8.
1992: Lon S Schneider; M F Zemansky; M Bender; R B Sloane
Personality in recovered depressed elderly.
International psychogeriatrics / IPA 1992;4(2):177-85.
1992: Lon S Schneider; P B Sobin
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Psychopharmacology bulletin 1992;28(1):71-9.
1991: Lon S Schneider; V E Pollock; M F Zemansky; R P Gleason; R Palmer; R B Sloane
A pilot study of low-dose L-deprenyl in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1991;4(3):143-8.
1991: V E Pollock; Lon S Schneider; Scott A Lyness
Reliability of topographic quantitative EEG amplitude in healthy late-middle-aged and elderly subjects.
Electroencephalography and clinical neurophysiology 1991;79(1):20-6.
1991: Lon S Schneider; V Pollock; Scott A Lyness
Further analysis of a meta-analysis.
Journal of the American Geriatrics Society 1991;39(4):441-2.
1991: F Hefti; Lon S Schneider
Nerve growth factor and Alzheimer's disease.
Clinical neuropharmacology 1991;14 Suppl 1():S62-76.
1991: Lon S Schneider; Scott A Lyness; S Pawluczyk; R P Gleason; R B Sloane
Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report.
Psychopharmacology bulletin 1991;27(3):309-14.
1990: V E Pollock; Lon S Schneider
The electroretinogram in Alzheimer's disease.
Annals of neurology 1990;28(5):724-5.
1990: V E Pollock; John Briere; Lon S Schneider; J Knop; Sarnoff A Mednick; D W Goodwin
Childhood antecedents of antisocial behavior: parental alcoholism and physical abusiveness.
The American journal of psychiatry 1990;147(10):1290-3.
1990: Lon S Schneider; T B Cooper; R F Suckow; Scott A Lyness; C Haugen; R Palmer; R B Sloane
Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Journal of clinical psychopharmacology 1990;10(5):333-7.
1990: K White; W Wykoff; L L Tynes; Lon S Schneider; M Zemansky
Fluvoxamine in the treatment of tricyclic-resistant depression.
Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Université d'Ottawa 1990;15(3):156-8.
1990: V E Pollock; Lon S Schneider
Topographic quantitative EEG in elderly subjects with major depression.
Psychophysiology 1990;27(4):438-44.
1990: J A Severson; Lon S Schneider; E R Fredrickson
Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
Psychiatry research 1990;33(1):19-29.
1990: Lon S Schneider; V E Pollock; Scott A Lyness
A metaanalysis of controlled trials of neuroleptic treatment in dementia.
Journal of the American Geriatrics Society 1990;38(5):553-63.
1990: V E Pollock; Lon S Schneider
Quantitative, waking EEG research on depression.
Biological psychiatry 1990;27(7):757-80.
1990: V E Pollock; Lon S Schneider; Scott A Lyness
EEG amplitudes in healthy, late-middle-aged and elderly adults: normality of the distributions and correlations with age.
Electroencephalography and clinical neurophysiology 1990;75(4):276-88.
1990: R P Gleason; Lon S Schneider
Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
The Journal of clinical psychiatry 1990;51(3):115-8.
1990: BA Kramer; V E Pollock; Lon S Schneider
Monitoring seizure duration during ECT.
The Journal of clinical psychiatry 1990;51(1):38-9.
1989: BA Kramer; V G Pollock; Lon S Schneider; G E Gray
ECT seizure monitoring.
Biological psychiatry 1989;26(8):848-50.
1989: P Sobin; Lon S Schneider; H McDermott
Fluoxetine in the treatment of agitated dementia.
The American journal of psychiatry 1989;146(12):1636.
1989: V E Pollock; Lon S Schneider
Topographic electroencephalographic alpha in recovered depressed elderly.
Journal of abnormal psychology 1989;98(3):268-73.
1989: V E Pollock; Lon S Schneider; Helena C Chui; Victor W. Henderson; M Zemansky; R B Sloane
Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer's disease patients.
Biological psychiatry 1989;25(8):1003-13.
1989: Lon S Schneider; R P Gleason; Helena C Chui
Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine.
Journal of geriatric psychiatry and neurology 1989;2(2):109-12.
1989: Victor W. Henderson; E Roberts; C Wimer; E L Bardolph; H C Chui; A R Damasio; P J Eslinger; MARSHAL FOLSTEIN; Lon S Schneider; Evelyn L Teng
Multicenter trial of naloxone in Alzheimer's disease.
Annals of neurology 1989;25(4):404-6.
1989: BA Kramer; V E Pollock; Lon S Schneider; G E Gray
Interrater reliability of MECTA SR-1 seizure duration.
Biological psychiatry 1989;25(5):642-4.
1989: V E Pollock; Lon S Schneider
Effects of tone stimulus frequency on late positive component activity (P3) among normal elderly subjects.
The International journal of neuroscience 1989;45(1-2):127-32.
1989: Lon S Schneider; R Gleason
Pharmacological treatment of symptomatic behaviors in dementia.
Journal of geriatric psychiatry and neurology 1989;2(1):57-8.
1989: F Hefti; Lon S Schneider
Rationale for the planned clinical trials with nerve growth factor in Alzheimer's disease.
Psychiatric developments 1989;7(4):297-315.
1988: Lon S Schneider; T B Cooper; J A Severson; T Zemplenyi; R B Sloane
Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
Journal of clinical psychopharmacology 1988;8(6):402-8.
1988: Lon S Schneider; J A Severson; R B Sloane; E R Fredrickson
Decreased platelet 3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly outpatients.
Journal of affective disorders 1988;15(2):195-200.
1988: Lon S Schneider; J A Severson; Helena C Chui; V E Pollock; R B Sloane; E R Fredrickson
Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
Psychiatry research 1988;25(3):311-22.
1988: Lon S Schneider; Helena C Chui; J A Severson; R B Sloane
Decreased platelet 3H-imipramine binding in Parkinson's disease.
Biological psychiatry 1988;24(3):348-51.
1987: V E Pollock; Lon S Schneider; W F Gabrielli; D W Goodwin
Sex of parent and offspring in the transmission of alcoholism. A meta-analysis.
The Journal of nervous and mental disease 1987;175(11):668-73.
1987: Lon S Schneider; T B Cooper; F R Staples; R B Sloane
Prediction of individual dosage of nortriptyline in depressed elderly outpatients.
Journal of clinical psychopharmacology 1987;7(5):311-4.
1987: Lon S Schneider; P J Syapin; S Pawluczyk
Seizures following triazolam withdrawal despite benzodiazepine treatment.
The Journal of clinical psychiatry 1987;48(10):418-9.
1987: Evelyn L Teng; H C Chui; Lon S Schneider; L E Metzger
Alzheimer's dementia: performance on the Mini-Mental State Examination.
Journal of consulting and clinical psychology 1987;55(1):96-100.
1987: Lon S Schneider; D Munjack; J A Severson; R Palmer
Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
Biological psychiatry 1987;22(1):59-66.
1986: Lon S Schneider; E R Fredrickson; J A Severson; R B Sloane
3H-imipramine binding in depressed elderly: relationship to family history and clinical response.
Psychiatry research 1986;19(4):257-66.
1986: Lon S Schneider; J A Severson; V Pollock; R P Cowan; R B Sloane
Platelet monoamine oxidase activity in elderly depressed outpatients.
Biological psychiatry 1986;21(14):1360-4.
1986: Lon S Schneider; H C Chui
Progressive supranuclear palsy manifesting with depressive features.
Journal of the American Geriatrics Society 1986;34(9):663-5.
1986: Lon S Schneider; R B Sloane; F R Staples; M Bender
Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression.
Journal of clinical psychopharmacology 1986;6(3):172-6.
1985: Lon S Schneider; J A Severson; R B Sloane
Platelet 3H-imipramine binding in depressed elderly patients.
Biological psychiatry 1985;20(11):1234-7.
1985: Lon S Schneider; Spencer Eth
Observations on misdiagnosis of rabies.
Psychosomatics 1985;26(4):338-40.
1985: Lon S Schneider
PSOP for response to imipramine and doxepin.
Journal of clinical psychopharmacology 1985;5(1):58-9.
1984: Lon S Schneider; M Plopper
Geropsychiatry and consultation-liaison services.
The American journal of psychiatry 1984;141(5):721-2.
1983: Lon S Schneider
Serial Sevens Test.
Archives of internal medicine 1983;143(3):612.